Neisseria meningitidis serogroup B polysaccharide capsule — Drug Target

All drugs that target Neisseria meningitidis serogroup B polysaccharide capsule — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Conjugate vaccine

Marketed (1)

• 4CMenb · CHU de Quebec-Universite Laval · Conjugate vaccine · Immunology / Infectious Disease
  4CMenb is a meningococcal serogroup B conjugate vaccine that stimulates immune responses against Neisseria meningitidis serogroup B.